BPH procedures compared: questions for surgery, minimally invasive therapy, and PAE

Confirm that the prostate is the treatment target

Lower urinary tract symptoms can come from the prostate, bladder, urethra, infection, neurologic conditions, medicines, or more than one cause. A procedure aimed at prostate tissue may not solve symptoms driven mainly by the bladder or another condition.

The evaluation may include a symptom score, urine testing, bladder-emptying measurement, PSA and exam when appropriate, prostate imaging, cystoscopy, urine-flow testing, or other studies. Ask which finding makes the proposed procedure a good fit.

Transurethral and laser procedures

Many procedures reach the prostate through the urethra. TURP removes obstructing tissue with an electrosurgical instrument. HoLEP enucleates obstructing tissue with a holmium laser. Photoselective vaporization (PVP) vaporizes tissue. Aquablation uses image-guided waterjet resection. The expected durability, bleeding risk, catheter use, anesthesia, recovery, retreatment possibility, pathology availability, and sexual side effects vary.

Do not compare technologies by the size of the incision alone. Ask how much tissue is treated, whether tissue is available for pathology, how the option performs for a prostate of this size and shape, and how often the treating clinician performs it.

Minimally invasive options

Office or outpatient therapies may use water vapor (Rezūm), permanent prostatic urethral implants (UroLift), or a temporary implantable nitinol device (iTind) to widen the channel or reduce the effect of obstructing tissue. A shorter procedure or recovery can be important, but it must be balanced with symptom improvement, anatomy limits, retreatment risk, catheter needs, implant considerations, and what happens if symptoms return.

Ask whether a median lobe, very large prostate, urinary retention, blood-thinning treatment, or another factor changes candidacy. Product marketing should not substitute for an anatomy-based recommendation.

Prostate artery embolization

Prostate artery embolization is performed by an interventional radiologist using a catheter to reduce blood flow to the prostate, which can cause the gland to shrink or soften. Availability and candidacy vary.

A PAE discussion should still include a urologic evaluation and shared decision-making about the lower-certainty evidence and retreatment tradeoffs. Ask how the team confirms BPH is the cause, whether the arterial anatomy can be treated safely, how radiation and contrast exposure are managed, which symptoms may improve, how long improvement may take, and what retreatment or surgery options remain.

Larger-gland and complication pathways

Very large prostates, repeated retention, stones, infections, bleeding, or bladder and kidney effects can change the balance toward a more definitive procedure. HoLEP can be used across a broad range of prostate sizes in experienced hands. Open, laparoscopic, or robotic simple prostatectomy may be considered for very large glands. The name “prostatectomy” can be confusing: surgery for BPH may remove obstructing tissue while leaving the outer prostate, while radical prostatectomy for cancer removes the gland. Confirm which operation is being discussed and why.

Qualitative comparison

Numeric improvement, complication, sexual-function, catheter, and retreatment rates are intentionally omitted because they vary by procedure, patient population, technique, and follow-up duration. Ask the treating clinician for outcomes that match the exact option and clinical situation being considered.

Build a same-option scorecard before choosing

Marketing pages often describe each procedure with a different success measure and follow-up period. Ask the clinician to compare every reasonable option across the same columns: the symptom or complication being treated, anatomy fit, expected degree and timing of improvement, anesthesia and catheter plan, bleeding and infection considerations, ejaculation and erectile-function effects, continence, tissue for pathology, recovery restrictions, durability evidence, retreatment pathway, clinician experience, and total patient cost.

Write “not known” when an outcome has not been measured for your situation. A shorter recovery claim should not erase a higher retreatment possibility, an anatomy limitation, or an outcome that matters more to you. Likewise, a more definitive procedure is not automatically the right choice when the burden or risk outweighs the expected benefit.

Compare outcomes that matter to you

Ask the clinician to compare the same outcomes across options:

Compare these points: likelihood and timing of symptom improvement; catheter use and expected recovery; bleeding, infection, anesthesia, and retreatment risk; effect on ejaculation, erection, continence, and fertility; need to stop or change blood-thinning medicines; whether tissue is obtained for pathology; what follow-up remains after the procedure.